Lista de obras -

A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation

artículo científico publicado en 2015

A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis

artículo científico publicado en 2010

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

artículo científico publicado en 2017

CCL3 (MIP-1α) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2

Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition

artículo científico publicado en 2012

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

artículo científico publicado en 2017

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.

artículo científico publicado en 2007

Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.

artículo científico publicado en 2015

Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice

artículo científico publicado en 2007

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

artículo científico publicado en 2007

Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release

artículo científico publicado en 2007

IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.

artículo científico publicado en 2015

IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation

artículo científico publicado en 2014

Immunogenicity of human neuroblastoma.

artículo científico publicado en 2004

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy

artículo científico publicado en 2016

Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

artículo científico publicado en 2013

Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications

artículo científico publicado en 2005

Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches

artículo científico publicado en 2014

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

artículo científico publicado en 2015

Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression

artículo científico publicado en 2013

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases

artículo científico publicado en 2016

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

artículo científico publicado en 2011

Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients

artículo científico publicado en 2011

Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients

artículo científico publicado en 2016

Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.

artículo científico publicado en 2011

Soluble HLA-G: Are they clinically relevant?

artículo científico publicado en 2007

Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke

artículo científico publicado en 2010

Lista de obras de

A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation

A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

CCL3 (MIP-1α) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2

Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.

Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.

Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release

IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.

IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation

Immunogenicity of human neuroblastoma.

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy

Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications

Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients

Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients

Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.

Soluble HLA-G: Are they clinically relevant?

Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke